Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats

Psychopharmacology

Volumn 226, Issue 1, 2013, Pages 13-24

  Campos, Alline Cristina ^a   De Paula Soares, Vanessa ^b   Carvalho, Milene C ^a   Ferreira, Frederico Rogerio ^a   Vicente, Maria Adrielle ^a   Brandão, Marcus Lira ^a   Zuardi, Antonio Waldo ^a   Zangrossi Jr , Hélio ^a   Guimarães, Francisco Silveira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

5 HT1A receptors; Cannabidiol; Dorsal periaqueductal gray; Panic disorder; Serotonin

Indexed keywords

CANNABIDIOL; MESSENGER RNA; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL PERIAQUEDUCTAL GRAY MATTER; DRUG EFFICACY; DRUG RECEPTOR BINDING; ESCAPE BEHAVIOR; EXTRACELLULAR MATRIX; FACILITATION; IN VIVO STUDY; MALE; MAZE TEST; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PANIC; PERIAQUEDUCTAL GRAY MATTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONIN RELEASE; TRANQUILIZING ACTIVITY; TREATMENT RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN MAPPING; CANNABIDIOL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MICRODIALYSIS; PANIC DISORDER; PERIAQUEDUCTAL GRAY; POLYMERASE CHAIN REACTION; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 84877156654     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2878-7     Document Type: Article

References (53)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th ed., text revision. American Psychiatric, Washington, DC
2. Bambico FR, Nguyen NT, Gobbi (2009) Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. Eur Neuropsychopharmacol 19(3):215-228
3. Bambico FR, Nguyen NT, Katz N, Gobbi G (2010) Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiol Dis 37(3):641-655
4. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I et al (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134(4):845-852
5. Campos AC, Guimarães FS (2008) Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacol (Berl) 199(2):223-230
6. Campos AC, Guimarães FS (2009) Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 33(8):1517-1521
7. Carrier EJ, Auchampach JA, Hillard CJ (2006) Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA 103(20):7895-7900
8. Casarotto PC, Gomes FV, Resstel LB, Guimarães FS (2010) Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors. Behav Pharmacol 21(4):353-358
9. Cassano T, Gaetani S, Macheda T, Laconca L, Romano A, Morgese MG et al (2011) Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacol (Berl) 214(2):465-476
10. Castro ME, Diaz A, del Olmo E, Pazos A (2003) Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44(1):93-101
11. Castro E, Díaz A, Rodriguez-Gaztelumendi A, Del Olmo E, Pazos A (2008) WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality. Neuropharmacology 55(8):1391-1396
12. de Paula Soares V, Zangrossi H Jr (2004) Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze. Brain Res Bull 64(2):181-188
13. de Souza Silva MA, Mattern C, Topic B, Buddenberg TE, Huston JP (2009) Dopaminergic and serotonergic activity in neostriatum and nucleus accumbens enhanced by intranasal administration of testosterone. Eur Neuropsychopharmacol 19(1):53-63
14. Deiana S, Watanabe A, Yamasaki Y, Amada N, Arthur M, Fleming S, Woodcock H, Dorward P, Pigliacampo B, Close S, Platt B, Riedel G (2011) Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacol (Berl) 219(3):859-873
15. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258(5090):1946-1949
16. Elbatsh MM, Assareh N, Marsden CA, Kendall DA (2012) Anxiogenic-like effects of chronic cannabidiol administration in rats. Psychopharmacol (Berl) 221:239-247
17. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, Martin-Santos R et al (2009) Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 66(1):95-105
18. Gomes FV, Resstel LB, Guimarães FS (2011) The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacol (Berl) 213(2-3):465-473
19. Graeff FG, Viana MB, Tomaz C (1993) The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Braz J Med Biol Res 26(1):67-70
20. Graeff FG, Netto CF, Zangrossi H Jr (1998) The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23(2):237-246
21. Guimarães FS, Chiaretti TM, Graeff FG, Zuardi AW (1990) Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacol (Berl) 100(4):558-559
22. Hershkowitz M, Szechtman H (1979) Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior. Eur J Pharmacol 59(3-4):267-276
23. Karrenbauer BD, Müller CP, Ho YJ, Spanagel R, Huston JP, Schwarting RK, Pawlak CR (2011) Time-dependent in-vivo effects of interleukin-2 on neurotransmitters in various cortices: relationships with depressive-related and anxiety-like behaviour. J Neuroimmunol 237(1-2):23-32
24. Kiser RS, Brown CA, Sanghera MK, German DC (1980) Dorsal raphe nucleus stimulation reduces centrally-elicited fearlike behavior. Brain Res 191(1):265-272
25. Mato S, Vidal R, Castro E, Díaz A, Pazos A, Valdizán EM (2010) Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1A receptor-dependent mechanisms. Mol Pharmacol 77(3):424-434
26. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50(1):83-90
27. Mishima K, Hayakawa K, Abe K, Ikeda T, Egashira N, Iwasaki K et al (2005) Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke 36(5):1077-1082
28. Moreira FA, Aguiar DC, Guimarães FS (2006) Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog Neuropsychopharmacol Biol Psychiatry 30(8):1466-1471
29. Moreira FA, Aguiar DC, Campos AC, Lisboa SF, Terzian AL, Resstel LB, et al. (2009) Antiaversive effects of cannabinoids: is the periaqueductal gray involved? Neural Plast 625469
30. Moulin-Sallanon M, Charnay Y, Ginovart N, Perret P, Lanfumey L, Hamon M et al (2009) Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins. Synapse 63(2):106-116
31. Nogueira RL, Graeff FG (1995) Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol Biochem Behav 52(1):1-6
32. Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253(3):1002-1009
33. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. Academic, New York
34. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. San Diego, Academic
35. Pinheiro SN, Del-Ben CM, Zangrossi H Jr, Graeff FG (2008) Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze. J Psychopharmacol 22(2):132-137
36. Pobbe RL, Zangrossi H Jr (2005) 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacol (Berl) 183(3):314-321
37. Poltronieri SC, Zangrossi H Jr, de Barros Viana M (2003) Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav Brain Res 147(1-2):185-192
38. Resstel LB, Joca SR, Moreira FA, Corrêa FM, Guimarães FS (2006) Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res 172(2):294-298
39. Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ et al (2011) Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic: Autoreceptors in the Dorsal Raphe Nucleus. Br J Pharmacol. doi: 10.1111/j.1476-5381.2011.01621.x
40. Roy-Byrne PP, Craske MG, Stein MB (2006) Panic disorder. Lancet 368:1023-1032
41. Russo EB, Burnett A, Hall B, Parker KK (2005) Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res 30(8):1037-1043
42. Schenberg LC, Bittencourt AS, Sudré EC, Vargas LC (2001) Modeling panic attacks. Neurosci Biobehav Rev 25(7-8):647-659
43. Soares Vde P, Campos AC, Bortoli VC, Zangrossi H Jr, Guimarães FS, Zuardi AW (2010) Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. Behav Brain Res 213(2):225-229
44. Teixeira RC, Zangrossi H, Graeff FG (2000) Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacol Biochem Behav 65(4):571-576
45. Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG (2007) Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol 150(5):613-623
46. Viana MB, Tomaz C, Graeff FG (1994) The elevated T-maze: a new animal model of anxiety and memory. Pharmacol Biochem Behav 49(3):549-554
47. Zangrossi H Jr, Graeff FG (1997) Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res Bull 44(1):1-5
48. Zanoveli JM, Nogueira RL, Zangrossi H Jr (2003) Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze. Eur J Pharmacol 473(2-3):153-161
49. Zanoveli JM, Nogueira RL, Zangrossi H Jr (2007) Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze. Neuropharmacology 52(4):1188-1195
50. Zanoveli JM, Carvalho MC, Cunha JM, Brandão ML (2009) Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: an in vivo microdialysis study. Brain Res 1294:106-115
51. Zanoveli JM, Pobbe RL, de Bortoli VC, Carvalho MC, Brandão ML, Zangrossi H Jr (2010) Facilitation of 5-HT(1A)-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine. Int J Neuropsychopharmacol 13(8):1079-1088
52. Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacol (Berl) 76(3):245-250
53. Zuardi AW, Guimarães FS, Moreira AC (1993) Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Braz J Med Biol Res 26(2):213-217